- July 03, 2023
- Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical to Provide Matching Funds to Select Crowdfunded Projects Addressing Issues in the Field of Oncology The Third "Taiho Smile Support"
Taiho Pharmaceutical Co., Ltd. announced today the launch of the third “Taiho Smile Support,” the company’s unique social contribution program. Under the program, Taiho Pharmaceutical will solicit project proposals on the theme of “Challenging Issues in the Field of Oncology” via its website from July 3 to September 30, 2023.
Taiho Smile Support is a social contribution program that supports organizations and individuals seeking to help solve various social issues in the field of oncology that cannot be solved by drugs alone. The program employs crowdfunding. If a selected organization or individual starts crowdfunding and is able to raise 50% of the amount needed to carry out the project, they will also receive matching funds from Taiho Pharmaceutical equal to 50% of the amount needed to carry out the project.
Taiho Smile Support: available only in Japanese
-
-
- e.g. If the target amount for project implementation is 1,000,000 yen.
-
Through this program, Taiho Pharmaceutical aims to support the dreams of organizations and individuals who are working to address challenges in the field of oncology. In partnership with these organizations, individuals, and all of the people who support them via crowdfunding, Taiho Pharmaceutical seeks to build a world where the precious moments of everyday life keep flowing for people with cancer and their families.
Third Taiho Smile Support
|
Application period |
July 3 to September 30, 2023 |
|
Target theme |
Challenging Issues in the Field of Oncology |
|
Result announcement |
Late November 2023 |
|
Crowdfunding implementation period |
November 2023 to April 30, 2024 |
|
Matching funds disbursement |
Early June 2024 |
|
Project implementation period |
June 2024 to May 2025 |
|
Project implementation report |
Please submit a report to Taiho Pharmaceutical within three months after the project implementation is completed. |
Information in this news release was current as of the original release date.
Taiho Pharmaceutical's press releases may contain information about prescription drugs including products currently under development, however information contained in the press releases are not intended to constitute promotion, advertisement, or medical advice.